William Blair Investment Management LLC raised its stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 1.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,166,552 shares of the company’s stock after purchasing an additional 15,467 shares during the quarter. William Blair Investment Management LLC owned approximately 1.18% of Encompass Health worth $141,724,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Gamco Investors INC. ET AL lifted its position in shares of Encompass Health by 2.0% in the 1st quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company’s stock worth $466,000 after purchasing an additional 94 shares during the period. GAMMA Investing LLC increased its position in shares of Encompass Health by 2.7% during the second quarter. GAMMA Investing LLC now owns 3,969 shares of the company’s stock valued at $401,000 after buying an additional 106 shares during the period. Childress Capital Advisors LLC increased its position in shares of Encompass Health by 5.1% during the third quarter. Childress Capital Advisors LLC now owns 2,189 shares of the company’s stock valued at $266,000 after buying an additional 106 shares during the period. Allworth Financial LP raised its stake in Encompass Health by 10.3% in the third quarter. Allworth Financial LP now owns 1,366 shares of the company’s stock worth $166,000 after buying an additional 127 shares in the last quarter. Finally, Pictet Asset Management Holding SA raised its stake in Encompass Health by 0.8% in the third quarter. Pictet Asset Management Holding SA now owns 16,037 shares of the company’s stock worth $1,948,000 after buying an additional 128 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.
Encompass Health Stock Performance
Shares of EHC stock opened at $140.86 on Monday. The company has a market capitalization of $13.82 billion, a price-to-earnings ratio of 22.01, a price-to-earnings-growth ratio of 2.44 and a beta of 0.83. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.09 and a current ratio of 1.09. Encompass Health Corporation has a one year low of $92.77 and a one year high of $143.90. The company’s 50-day moving average is $126.70 and its 200 day moving average is $112.02.
Encompass Health (NYSE:EHC – Get Free Report) last issued its earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.16. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.60 billion. Encompass Health had a net margin of 10.17% and a return on equity of 18.35%. The business’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.23 earnings per share. Sell-side analysts expect that Encompass Health Corporation will post 6.29 EPS for the current fiscal year.
Encompass Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.84 annualized dividend and a dividend yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is 13.12%.
Insider Buying and Selling at Encompass Health
In related news, EVP John Darby sold 4,858 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares of the company’s stock, valued at $9,086,714.69. This trade represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
EHC has been the subject of several research analyst reports. KeyCorp raised their price objective on shares of Encompass Health from $147.00 to $150.00 and gave the stock an “overweight” rating in a report on Friday, October 30th. Raymond James Financial reissued a “strong-buy” rating and set a $155.00 price objective on shares of Encompass Health in a research note on Friday, October 30th. Truist Financial restated a “buy” rating and issued a $156.00 price objective (up from $150.00) on shares of Encompass Health in a report on Friday, October 30th. TD Cowen raised their target price on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, October 30th. Finally, Barclays lifted their target price on shares of Encompass Health from $144.00 to $151.00 and gave the company an “overweight” rating in a report on Thursday, October 29th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $154.25.
Read Our Latest Stock Report on Encompass Health
Encompass Health Company Profile
Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.
Featured Stories
- Five stocks we like better than Encompass Health
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
